Two sickle cell disease researchers will share a $3 million Breakthrough Prize for discoveries that changed the treatment ...

Etavopivat improved hemoglobin levels and reduced pain crises in a Phase 3 sickle cell disease trial, supporting potential ...

Newly diagnosed with DVT and a pulmonary embolism, columnist Michelle Harlan finds herself in an unfamiliar relationship with ...

Having a remote job has been a game-changer for me as someone with sickle cell disease. I’m better able to manage my health — no rushed mornings, cold commutes, or physical strain. I can plan my day ...

People with sickle cell disease in Africa are less likely to use common treatments and may report lower burden, a global ...

Bias in sickle cell care may be tied to opioid stigma, with patients more often described negatively in medical records, a ...

The isolation of chronic disease isn't just about being physically alone; it's also emotional and social, says columnist ...

A new, interactive application touted as the first of its kind can help people with sickle cell disease (SCD) learn about and communicate with their care team about their pain attacks. People with ...

The European Medicines Agency (EMA) has confirmed the continuing suspension of marketing authorization for Pfizer’s sickle cell disease (SCD) treatment Oxbryta (voxelotor) — withdrawn from the market ...

When successful, a stem cell transplant can be a cure for sickle cell disease (SCD). However, the procedure carries substantial risks and is not an option for all patients. Other therapeutic ...

Sickle cell anemia is an inherited blood disorder that can cause debilitating pain crises and put patients at increased risk for infections, among other symptoms. There are several treatments that can ...

Sickle cell disease (SCD) may be cured in some individuals by a stem cell transplant. There also are several approved therapies to help manage the condition and its related complications. Some of the ...